Nifty

:

24056.00

Sensex

:

77100.47

34.35 (0.14%)
109.25 (0.14%)

Login

Nifty
Sensex

:
:

24056.00
77100.47

34.35 (0.14%)
109.25 (0.14%)

FDC Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

59/99

BSE: 531599 | NSE: FDC

Watchlist

NSE BSE

408.30

25-Jun-2026

Open
High
Low
Previous Close

412
420.9
406.15
410.65

Volume
Traded Value (lacs)
52 Week High
52 Week Low

218868
90609319.75
527.8
312.95

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

6,661.37
23.67
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

6,622.59
N/A
2.68

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

7.80
9.60
5.73

EBITDA CAGR (%)

10 Years
5 Years
3 Years

3.57
-0.56
5.41

PAT CAGR (%)

10 Years
5 Years
3 Years

4.69
-2.41
11.20

P:E (Median)

8 Years
5 Years
3 Years

23.15
25.60
26.71

P:BV (Average)

8 Years
5 Years
3 Years

2.87
2.93
3.19

EV:EBITDA (Average)

8 Years
5 Years
3 Years

14.67
16.14
17.33

Earnings Forecasts:

(Updated: 23-06-2026)

Description 2026 2027 2028 2029
Adj EPS - - - -
P/E Ratio - - - -
Revenue - - - -
EBITDA - - - -
Net Income - - - -
ROA - - - -
P/B Ratio - - - -
ROE - - - -
FCFF - - - -
FCFF Yield - - - -
Net Debt - - - -
BVPS - - - -

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var%
Net Sales 564.36 482.00 17.09% 457.94 458.86 -0.20% 461.74 505.10 -8.58% 642.28 624.14 2.91%
Expenses 452.75 429.18 5.49% 408.33 412.92 -1.11% 426.85 432.70 -1.35% 500.94 482.45 3.83%
EBITDA 111.61 52.83 111.26% 49.61 45.94 7.99% 34.89 72.40 -51.81% 141.34 141.69 -0.25%
EBIDTM 19.78% 10.96% 10.83% 10.01% 7.56% 14.33% 22.01% 22.70%
Other Income 47.16 31.43 50.05% 22.07 18.64 18.40% 20.91 34.68 -39.71% 35.59 28.15 26.43%
Interest 1.50 1.18 27.12% 1.12 0.94 19.15% 1.15 1.07 7.48% 1.16 1.29 -10.08%
Depreciation 14.31 15.53 -7.86% 14.75 13.32 10.74% 15.17 13.76 10.25% 14.88 11.00 35.27%
PBT 142.96 67.54 111.67% 35.02 50.32 -30.41% 39.49 92.25 -57.19% 160.88 157.56 2.11%
Tax 35.89 19.33 85.67% 7.83 13.87 -43.55% 10.02 18.28 -45.19% 38.69 42.57 -9.11%
PAT 107.07 48.21 122.09% 27.19 36.45 -25.40% 29.48 73.97 -60.15% 122.19 114.99 6.26%
PATM 18.97% 10.00% 5.94% 7.94% 6.38% 14.65% 19.02% 18.42%
EPS 6.58 2.96 122.30% 1.67 2.24 -25.45% 1.81 4.54 -60.13% 7.51 7.06 6.37%

Description Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var%
Net Sales 584.79 491.89 18.89% 464.71 464.11 0.13% 473.03 513.85 -7.94% 648.41 638.27 1.59%
Expenses 478.43 437.91 9.25% 412.43 417.46 -1.20% 439.21 443.69 -1.01% 508.06 491.65 3.34%
EBITDA 106.36 53.98 97.04% 52.28 46.65 12.07% 33.82 70.16 -51.80% 140.34 146.62 -4.28%
EBIDTM 18.19% 10.97% 11.25% 10.05% 7.15% 13.65% 21.64% 22.97%
Other Income 49.89 16.08 210.26% 20.80 18.83 10.46% 20.62 34.70 -40.58% 35.50 28.44 24.82%
Interest 1.55 1.19 30.25% 1.12 0.95 17.89% 1.15 1.07 7.48% 1.17 1.30 -10.00%
Depreciation 14.36 15.56 -7.71% 14.78 13.36 10.63% 15.20 13.79 10.22% 14.91 11.02 35.30%
PBT 140.35 53.31 163.27% 36.38 51.18 -28.92% 38.09 90.00 -57.68% 159.78 162.73 -1.81%
Tax 36.95 14.64 152.39% 8.08 14.14 -42.86% 9.72 17.96 -45.88% 38.42 43.70 -12.08%
PAT 103.40 38.67 167.39% 28.30 37.04 -23.60% 28.37 72.04 -60.62% 121.35 119.04 1.94%
PATM 17.68% 7.86% 6.09% 7.98% 6.00% 14.02% 18.72% 18.65%
EPS 6.35 2.38 166.81% 1.74 2.27 -23.35% 1.74 4.42 -60.63% 7.45 7.31 1.92%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 2,126.32 2,070.11 1,916.19 1,777.03 1,518.97 1,325.45 1,331.09 1,075.87 1,062.20 1,008.91 986.81 Net Sales Growth 2.72% 8.03% 7.83% 16.99% 14.60% -0.42% 23.72% 1.29% 5.28% 2.24% Cost Of Goods Sold 689.01 724.39 645.81 654.26 527.84 412.05 424.53 344.49 349.98 338.09 355.07 Gross Profit 1,437.31 1,345.72 1,270.37 1,122.77 991.12 913.40 906.56 731.39 712.22 670.81 631.74 GP Margin 67.60% 65.01% 66.30% 63.18% 65.25% 68.91% 68.11% 67.98% 67.05% 66.49% 64.02% Total Expenditure 1,788.87 1,749.86 1,577.73 1,523.84 1,272.12 1,001.12 1,047.51 855.83 843.10 766.96 759.85 Power & Fuel Cost - 39.38 37.38 34.08 28.89 27.06 27.38 24.60 21.98 21.52 23.12 % Of Sales - 1.90% 1.95% 1.92% 1.90% 2.04% 2.06% 2.29% 2.07% 2.13% 2.34% Employee Cost - 477.22 408.99 386.99 339.97 294.31 276.18 226.19 215.47 189.93 174.53 % Of Sales - 23.05% 21.34% 21.78% 22.38% 22.20% 20.75% 21.02% 20.29% 18.83% 17.69% Manufacturing Exp. - 165.28 170.27 154.77 128.20 98.08 90.88 81.00 75.08 61.44 48.58 % Of Sales - 7.98% 8.89% 8.71% 8.44% 7.40% 6.83% 7.53% 7.07% 6.09% 4.92% General & Admin Exp. - 110.16 103.67 99.60 69.39 54.95 57.18 58.56 60.53 52.70 49.55 % Of Sales - 5.32% 5.41% 5.60% 4.57% 4.15% 4.30% 5.44% 5.70% 5.22% 5.02% Selling & Distn. Exp. - 200.97 181.93 168.58 147.47 87.68 94.70 78.94 75.96 64.36 57.73 % Of Sales - 9.71% 9.49% 9.49% 9.71% 6.62% 7.11% 7.34% 7.15% 6.38% 5.85% Miscellaneous Exp. - 32.46 29.68 25.56 30.36 26.99 76.66 42.06 44.10 38.89 57.73 % Of Sales - 1.57% 1.55% 1.44% 2.00% 2.04% 5.76% 3.91% 4.15% 3.85% 5.20% EBITDA 337.45 320.25 338.46 253.19 246.85 324.33 283.58 220.04 219.10 241.95 226.96 EBITDA Margin 15.87% 15.47% 17.66% 14.25% 16.25% 24.47% 21.30% 20.45% 20.63% 23.98% 23.00% Other Income 125.73 105.52 103.22 55.29 78.73 97.15 82.66 54.80 51.25 49.65 39.98 Interest 4.93 4.49 4.00 4.04 3.05 3.40 3.41 1.43 1.40 1.41 1.40 Depreciation 59.11 53.61 39.73 38.76 37.08 37.62 37.36 33.14 35.04 34.52 33.61 PBT 378.35 367.67 397.95 265.69 285.45 380.45 325.46 240.27 233.91 255.67 231.94 Tax 92.43 94.05 90.78 64.72 65.82 85.96 78.68 64.76 65.59 62.72 63.03 Tax Rate 24.43% 25.58% 22.81% 24.36% 23.06% 22.59% 24.18% 27.41% 28.04% 25.11% 27.18% PAT 285.93 273.63 307.16 200.97 219.64 294.49 246.78 171.54 168.31 187.07 168.90 PAT before Minority Interest 285.93 273.63 307.16 200.97 219.64 294.49 246.78 171.54 168.31 187.07 168.90 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 13.45% 13.22% 16.03% 11.31% 14.46% 22.22% 18.54% 15.94% 15.85% 18.54% 17.12% PAT Growth 4.50% -10.92% 52.84% -8.50% -25.42% 19.33% 43.86% 1.92% -10.03% 10.76% EPS 17.56 16.81 18.87 12.34 13.49 18.09 15.16 10.54 10.34 11.49 10.37

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 2,170.94 2,108.12 1,942.94 1,783.75 1,527.92 1,333.20 1,344.19 1,090.70 1,075.07 1,013.87 994.32 Net Sales Growth 2.98% 8.50% 8.92% 16.74% 14.61% -0.82% 23.24% 1.45% 6.04% 1.97% Cost Of Goods Sold 710.97 736.27 656.15 655.79 530.21 414.07 425.72 345.14 352.08 339.05 357.93 Gross Profit 1,459.97 1,371.84 1,286.79 1,127.96 997.71 919.14 918.46 745.56 722.99 674.81 636.38 GP Margin 67.25% 65.07% 66.23% 63.24% 65.30% 68.94% 68.33% 68.36% 67.25% 66.56% 64.00% Total Expenditure 1,838.13 1,783.32 1,604.41 1,534.16 1,274.23 999.15 1,051.25 859.68 848.38 770.40 765.58 Power & Fuel Cost - 39.38 37.38 34.12 28.91 27.08 27.40 24.61 22.00 21.55 23.14 % Of Sales - 1.87% 1.92% 1.91% 1.89% 2.03% 2.04% 2.26% 2.05% 2.13% 2.33% Employee Cost - 482.37 413.40 390.90 343.33 296.29 277.48 225.57 216.67 191.08 175.76 % Of Sales - 22.88% 21.28% 21.91% 22.47% 22.22% 20.64% 20.68% 20.15% 18.85% 17.68% Manufacturing Exp. - 165.33 171.89 154.81 128.24 98.11 90.93 81.06 75.14 61.50 48.64 % Of Sales - 7.84% 8.85% 8.68% 8.39% 7.36% 6.76% 7.43% 6.99% 6.07% 4.89% General & Admin Exp. - 114.49 107.33 101.01 70.29 55.64 58.06 59.45 61.55 53.35 49.97 % Of Sales - 5.43% 5.52% 5.66% 4.60% 4.17% 4.32% 5.45% 5.73% 5.26% 5.03% Selling & Distn. Exp. - 211.27 187.19 171.01 147.96 87.74 94.70 78.92 75.96 64.36 57.73 % Of Sales - 10.02% 9.63% 9.59% 9.68% 6.58% 7.05% 7.24% 7.07% 6.35% 5.81% Miscellaneous Exp. - 34.20 31.06 26.53 25.28 20.23 76.95 44.92 44.98 39.51 57.73 % Of Sales - 1.62% 1.60% 1.49% 1.65% 1.52% 5.72% 4.12% 4.18% 3.90% 5.27% EBITDA 332.80 324.80 338.53 249.59 253.69 334.05 292.94 231.02 226.69 243.47 228.74 EBITDA Margin 15.33% 15.41% 17.42% 13.99% 16.60% 25.06% 21.79% 21.18% 21.09% 24.01% 23.00% Other Income 126.81 90.66 101.63 51.24 76.09 97.03 68.90 43.47 50.96 50.22 39.00 Interest 4.99 4.51 4.03 4.09 3.09 3.43 3.42 1.44 1.40 1.41 1.40 Depreciation 59.25 53.73 39.92 38.94 37.30 37.81 37.46 33.24 35.14 34.62 33.73 PBT 374.60 357.22 396.22 257.80 289.39 389.83 320.97 239.80 241.11 257.65 232.62 Tax 93.17 90.43 91.16 63.98 73.23 86.53 80.08 66.85 67.12 63.30 63.48 Tax Rate 24.87% 25.31% 23.01% 24.82% 25.30% 22.32% 24.95% 28.01% 27.84% 25.14% 27.29% PAT 281.42 266.79 305.06 194.04 216.40 301.35 239.88 169.79 173.51 188.53 168.67 PAT before Minority Interest 281.42 266.79 305.06 193.83 216.16 301.20 239.88 169.79 173.51 188.53 168.67 Minority Interest 0.00 0.00 0.00 0.21 0.24 0.15 0.00 0.00 0.00 0.00 0.00 PAT Margin 12.96% 12.66% 15.70% 10.88% 14.16% 22.60% 17.85% 15.57% 16.14% 18.60% 16.96% PAT Growth 5.48% -12.55% 57.22% -10.33% -28.19% 25.63% 41.28% -2.14% -7.97% 11.77% EPS 17.29 16.39 18.74 11.92 13.29 18.51 14.73 10.43 10.66 11.58 10.36

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 2,287.19 2,097.20 1,980.74 1,948.69 1,722.17 1,541.82 1,433.04 1,262.40 1,263.72 1,076.53 Share Capital 16.28 16.28 16.59 16.88 16.88 17.10 17.52 17.52 17.86 17.86 Total Reserves 2,270.91 2,080.92 1,964.15 1,931.80 1,705.28 1,524.72 1,415.52 1,244.88 1,245.86 1,058.67 Non-Current Liabilities 808.92 597.62 462.65 384.43 299.56 314.62 229.17 211.41 216.67 19.93 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.03 0.11 0.21 0.34 0.49 0.60 0.69 0.79 Long Term Provisions 776.87 574.35 436.75 349.81 281.24 295.78 213.96 194.12 198.60 0.50 Current Liabilities 543.70 612.23 728.67 688.60 620.07 562.37 494.21 476.08 387.41 162.11 Trade Payables 201.52 184.63 178.48 136.26 76.66 117.54 77.20 96.95 74.66 82.30 Other Current Liabilities 122.59 99.96 95.93 85.87 76.83 79.53 60.88 66.76 63.10 49.58 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 219.60 327.64 454.27 466.47 466.59 365.29 356.13 312.37 249.65 30.24 Total Liabilities 3,639.81 3,307.05 3,172.06 3,021.72 2,641.80 2,418.81 2,156.42 1,949.89 1,867.80 1,258.57 Net Block 847.50 676.39 694.93 700.97 685.02 669.77 678.47 669.75 674.50 670.89 Gross Block 1,175.85 985.51 971.79 942.26 890.57 840.73 813.68 772.29 742.10 704.26 Accumulated Depreciation 328.35 309.12 276.86 241.29 205.56 170.96 135.21 102.53 67.61 33.36 Non Current Assets 2,383.07 1,947.92 1,730.32 1,615.15 1,299.40 1,177.74 1,109.97 973.09 954.70 738.52 Capital Work in Progress 136.17 260.88 197.84 104.36 19.21 23.85 12.38 12.84 6.32 19.92 Non Current Investment 565.07 399.70 348.71 384.95 265.58 162.53 179.33 74.40 54.82 39.76 Long Term Loans & Adv. 833.19 609.50 487.39 424.04 328.73 320.85 239.11 215.61 218.61 7.70 Other Non Current Assets 1.13 1.45 1.45 0.84 0.87 0.73 0.68 0.47 0.45 0.25 Current Assets 1,253.32 1,355.13 1,439.89 1,406.56 1,338.24 1,241.06 1,046.45 976.80 913.10 520.05 Current Investments 484.65 450.03 457.29 500.77 524.84 502.24 405.93 397.16 436.53 285.41 Inventories 367.70 383.47 323.34 303.63 213.27 209.49 172.73 159.65 136.22 130.24 Sundry Debtors 103.88 114.61 121.25 79.71 107.80 124.19 83.52 76.71 77.46 64.03 Cash & Bank 40.97 21.65 20.80 32.06 26.86 28.96 15.70 21.12 23.02 13.50 Other Current Assets 256.11 20.11 12.26 11.46 465.45 376.17 368.57 322.16 239.86 26.88 Short Term Loans & Adv. 241.48 365.27 504.94 478.94 450.07 349.81 357.56 311.65 230.44 20.30 Net Current Assets 709.62 742.91 711.22 717.96 718.17 678.69 552.24 500.72 525.69 357.93 Total Assets 3,636.39 3,303.05 3,170.21 3,021.71 2,637.64 2,418.80 2,156.42 1,949.89 1,867.80 1,258.57

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 2,281.08 2,097.17 1,982.05 1,956.79 1,734.13 1,547.43 1,445.24 1,276.11 1,270.20 1,082.47 Share Capital 16.28 16.28 16.59 16.88 16.88 17.10 17.52 17.52 17.86 17.86 Total Reserves 2,264.80 2,080.89 1,965.46 1,939.91 1,717.25 1,530.33 1,427.72 1,258.59 1,252.34 1,064.61 Non-Current Liabilities 811.89 604.16 468.64 391.17 299.63 314.62 229.17 211.41 216.67 19.93 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.11 0.25 0.56 0.65 0.72 0.34 0.49 0.60 0.69 0.79 Long Term Provisions 776.87 574.35 436.75 349.81 281.24 295.78 213.96 194.12 198.60 0.50 Current Liabilities 550.33 615.18 729.56 690.40 621.79 564.62 497.43 480.07 389.40 163.42 Trade Payables 205.15 186.03 178.49 136.94 77.28 117.86 77.61 97.32 75.10 82.59 Other Current Liabilities 124.62 101.50 96.59 86.44 77.36 80.06 61.67 68.78 64.11 50.16 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 220.56 327.64 454.48 467.01 467.15 366.69 358.15 313.97 250.19 30.67 Total Liabilities 3,643.30 3,316.51 3,179.61 3,037.93 2,655.38 2,426.67 2,171.84 1,967.59 1,876.27 1,265.82 Net Block 851.55 680.26 698.92 705.06 689.15 673.50 682.19 673.64 678.05 675.16 Gross Block 1,181.74 987.18 973.27 949.42 897.55 844.97 817.80 776.49 745.84 708.81 Accumulated Depreciation 330.19 306.92 274.35 244.36 208.40 171.47 135.61 102.84 67.79 33.65 Non Current Assets 2,365.89 1,945.46 1,734.70 1,619.50 1,303.33 1,181.25 1,113.46 976.64 957.93 742.46 Capital Work in Progress 136.84 261.48 198.44 104.82 19.21 23.85 12.38 12.84 6.32 19.92 Non Current Investment 543.17 392.76 348.49 384.73 265.36 162.31 179.11 74.07 54.49 39.43 Long Term Loans & Adv. 833.20 609.51 487.41 424.05 328.74 320.85 239.11 215.61 218.61 7.70 Other Non Current Assets 1.13 1.45 1.45 0.84 0.87 0.73 0.68 0.47 0.45 0.25 Current Assets 1,273.98 1,367.05 1,443.06 1,418.43 1,347.90 1,245.41 1,058.38 990.94 918.34 523.36 Current Investments 484.65 450.03 457.29 500.77 524.84 502.24 405.93 397.16 436.53 285.41 Inventories 375.03 388.89 328.54 304.70 214.92 209.96 173.79 160.49 137.16 130.91 Sundry Debtors 108.85 117.38 122.65 82.17 110.54 123.74 87.53 81.66 76.06 61.94 Cash & Bank 52.77 26.29 24.94 38.66 31.58 32.32 21.26 29.30 28.47 18.02 Other Current Assets 252.68 19.19 9.94 11.70 466.02 377.15 369.88 322.33 240.12 27.10 Short Term Loans & Adv. 241.57 365.27 499.69 480.43 450.41 350.34 358.56 311.65 230.44 20.36 Net Current Assets 723.65 751.87 713.50 728.03 726.11 680.79 560.94 510.87 528.94 359.94 Total Assets 3,639.87 3,312.51 3,177.76 3,037.93 2,651.23 2,426.66 2,171.84 1,967.58 1,876.27 1,265.82

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 310.34 220.81 164.72 162.38 209.84 239.04 103.79 147.76 153.09 171.09 PBT 367.67 397.95 265.69 285.45 380.45 325.46 240.27 233.91 255.67 231.94 Adjustment -39.91 -52.32 1.00 -23.59 -40.75 8.36 -13.54 -1.86 -11.07 0.24 Changes in Working Capital 85.40 -21.91 -25.11 -21.17 -36.05 -11.00 -51.34 -16.54 -18.76 -5.75 Cash after chg. in Working capital 413.16 323.71 241.58 240.69 303.65 322.82 175.38 215.50 225.84 226.42 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -102.82 -102.90 -76.86 -78.31 -93.81 -83.78 -71.60 -67.75 -69.78 -55.33 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -2.97 0.00 Cash From Investing Activity -199.45 -17.76 3.62 -147.42 -84.18 -84.80 -109.30 20.15 -143.55 -72.76 Net Fixed Assets -65.63 -76.76 -123.01 -136.84 -45.20 -38.52 -40.93 -36.71 -24.24 -81.62 Net Investments -199.99 -43.73 79.72 -95.30 -125.65 -79.51 -113.70 19.79 -166.18 170.44 Others 66.17 102.73 46.91 84.72 86.67 33.23 45.33 37.07 46.87 -161.58 Cash from Financing Activity -92.10 -202.03 -179.83 -9.70 -126.49 -142.00 -0.07 -169.43 0.35 -96.98 Net Cash Inflow / Outflow 18.79 1.02 -11.48 5.26 -0.83 12.24 -5.58 -1.53 9.90 1.36 Opening Cash & Equivalents 20.77 19.75 31.13 25.72 26.52 14.36 19.94 21.66 11.74 10.58 Closing Cash & Equivalent 39.67 20.77 19.75 31.13 25.72 26.52 14.36 19.94 21.66 11.74

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 317.57 220.77 154.91 161.65 207.08 250.38 112.43 149.84 154.49 174.30 PBT 357.22 396.22 257.80 289.39 389.85 319.95 237.75 240.63 257.71 232.15 Adjustment -24.78 -51.18 4.32 -26.48 -48.34 22.58 -0.21 0.39 -10.88 2.41 Changes in Working Capital 87.94 -20.35 -29.91 -21.72 -39.42 -7.77 -51.05 -23.24 -19.23 -4.54 Cash after chg. in Working capital 420.37 324.69 232.21 241.19 302.09 334.77 186.49 217.78 227.60 230.02 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -102.80 -103.92 -77.30 -79.54 -95.01 -84.39 -74.06 -67.94 -70.14 -55.73 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -2.97 0.00 Cash From Investing Activity -199.51 -17.08 11.13 -144.57 -77.15 -98.35 -120.33 20.11 -143.55 -73.05 Net Fixed Assets -65.63 -76.76 -123.01 -136.84 -45.20 -38.52 -40.93 -36.71 -24.24 -81.62 Net Investments -199.99 -43.73 79.72 -95.30 -125.65 -79.51 -113.70 19.79 -166.18 170.44 Others 66.11 103.41 54.42 87.57 93.70 19.68 34.30 37.03 46.87 -161.87 Cash from Financing Activity -92.12 -202.16 -179.95 -9.84 -129.35 -142.00 -0.07 -169.43 0.35 -96.98 Net Cash Inflow / Outflow 25.94 1.53 -13.90 7.25 0.58 10.03 -7.96 0.52 11.29 4.27 Opening Cash & Equivalents 25.42 23.89 37.73 30.43 29.88 19.92 28.13 27.10 16.25 12.17 Closing Cash & Equivalent 51.47 25.42 23.89 37.73 30.43 29.88 19.92 28.13 27.10 16.25

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 140.48 128.81 119.39 115.44 102.02 90.18 82.16 72.38 71.06 60.53 ROA 7.88% 9.48% 6.49% 7.76% 11.64% 10.79% 8.35% 8.82% 11.97% 14.09% ROE 12.48% 15.06% 10.23% 11.97% 18.04% 16.59% 12.73% 13.33% 15.99% 16.85% ROCE 16.98% 19.71% 13.70% 15.66% 23.43% 22.06% 17.63% 18.62% 21.45% 23.25% Fixed Asset Turnover 1.98 2.02 1.91 1.71 1.57 1.65 1.39 1.41 1.45 1.53 Receivable days 18.66 21.82 20.01 21.87 31.18 27.76 26.53 26.29 24.69 22.54 Inventory Days 64.14 65.39 62.44 60.30 56.83 51.08 55.04 50.45 46.49 45.50 Payable days 97.28 102.61 87.79 73.61 86.01 38.13 40.20 41.31 40.79 44.71 Cash Conversion Cycle -14.49 -15.40 -5.34 8.56 2.00 40.71 41.37 35.43 30.39 23.32 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 82.92 100.49 66.79 94.65 112.82 96.31 166.02 167.77 178.52 167.05

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 140.11 128.81 119.47 115.92 102.73 90.51 82.86 73.17 71.42 60.87 ROA 7.67% 9.39% 6.23% 7.59% 11.85% 10.48% 8.30% 9.05% 12.00% 14.01% ROE 12.19% 14.96% 9.84% 11.71% 18.36% 16.10% 12.63% 13.67% 16.02% 16.76% ROCE 16.52% 19.62% 13.27% 15.78% 23.74% 21.63% 17.64% 19.04% 21.51% 23.15% Fixed Asset Turnover 2.01 2.04 1.91 1.70 1.57 1.66 1.41 1.42 1.44 1.52 Receivable days 18.98 21.91 20.32 22.35 31.31 27.96 27.55 26.58 23.96 22.06 Inventory Days 64.09 65.48 62.83 60.27 56.79 50.80 54.43 50.15 46.55 45.58 Payable days 96.96 101.39 87.78 73.73 86.01 38.19 40.35 41.32 40.83 44.81 Cash Conversion Cycle -13.89 -14.00 -4.62 8.89 2.09 40.57 41.62 35.41 29.68 22.84 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 80.21 99.22 64.07 94.67 113.90 94.95 166.95 172.62 179.60 167.11

Top Investors:

icici prudential smallcap fund

nippon life india trustee ltd-a/c nippon india small cap fund

investor education and protection fund (iepf)

Annual Reports:

News Update:

FDC - Quarterly Results
28th May 2026, 00:00 AM

Read More
FDC gets USFDA’s nod for Cefixime for Oral Suspension
18th May 2026, 11:52 AM

The company has received abbreviated new drug application approval from USFDA
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback